The Medicines and Healthcare products Regulatory Agency (MHRA) and the National Institute for Health and Care Excellence (NICE) have received £1.8 million to explore and produce guidance on regulating digital mental health tools.
MHRA will use the funding to improve clarity around whether mental health products should be considered medical devices and the risk classification they would fall under, as well as a review of the current evidence base for these devices. The funding, which was provided by health and wellbeing researcher Wellcome, will last for three years to "help improve regulatory certainty and safety" on digital mental health devices, which have increased in number in recent years, particularly during the Covid-19 pandemic. Dr Caroline Johnson, minister for mental health, said that while digital m...
To continue reading this article...
Join COVER for free
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.